Page last updated: 2024-11-07

oxandrolone and Depression

oxandrolone has been researched along with Depression in 3 studies

Oxandrolone: A synthetic hormone with anabolic and androgenic properties.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research Excerpts

ExcerptRelevanceReference
"Oxandrolone (OXA) is an androgen and anabolic steroid (AAS) that is used to reverse weight loss associated with some medical conditions."5.62Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-α. ( Abed, AF; Alfaraj, M; Hall, FS; Hammad, AM; Ibrahim, YA; Jarrar, Y; Khdair, SI, 2021)
"Oxandrolone (OXA) is an androgen and anabolic steroid (AAS) that is used to reverse weight loss associated with some medical conditions."1.62Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-α. ( Abed, AF; Alfaraj, M; Hall, FS; Hammad, AM; Ibrahim, YA; Jarrar, Y; Khdair, SI, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hammad, AM1
Ibrahim, YA1
Khdair, SI1
Hall, FS1
Alfaraj, M1
Jarrar, Y1
Abed, AF1
Freriks, K1
Verhaak, CM1
Sas, TC1
Menke, LA1
Wit, JM1
Otten, BJ1
de Muinck Keizer-Schrama, SM1
Smeets, DF1
Netea-Maier, RT1
Hermus, AR1
Kessels, RP1
Timmers, HJ1
Ross, JL1
Kushner, H1
Kowal, K1
Bardsley, M1
Davis, S1
Reiss, AL1
Tartaglia, N1
Roeltgen, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Androgen Effect on Motor/Cognitive Outcome in Klinefelter Syndrome[NCT00348946]Phase 293 participants (Actual)Interventional2006-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Psychosocial and Behavior Domain

Outcome measures were tested using The Piers-Harris Self Concept Scale. Scoring provides a total standard score and scores on six subscales: physical appearance and attributes, freedom from anxiety, intellectual and school status, behavioral adjustment, happiness and satisfaction, and popularity. Subscales are summed and standardized to provide the total standard score with a mean of 100 and SD of 15. The minimum standard score is 50; the maximum standard score is 145. Higher scores imply better function. (NCT00348946)
Timeframe: 2 years per subject

Interventionunits on a scale (Mean)
Oxandrolone105
Placebo100

Cognitive Function and Language

Outcome measures were tested using the Differential Ability Scales - 2nd edition (DAS-II). DAS-II provides an age- and sex-standardized assessment of intellectual functioning (General Concept Ability subscale similar to IQ) in children ages 2-17 years of age (mean=100, SD=15). The Verbal Cluster measures the child's ability to define words and perform verbal reasoning tasks. The Nonverbal Cluster measures the child's inductive and sequential reasoning abilities. The Spatial Cluster measures visuospatial construction ability, spatial memory, and spatial reasoning. Data is expressed as standard scores with mean of 100 and SD of 15. The minimum standard score is 50; the maximum standard score is 145. Higher scores imply better function. (NCT00348946)
Timeframe: 2 years per subject

,
Interventionscore on a scale (Mean)
DAS: General Concept AbilityDAS: Verbal ClusterDAS: Nonverbal ClusterDAS: Spatial Cluster
Oxandrolone969210296
Placebo949010194

Motor Function/Strength

Outcome measures were tested using the following assessments: Bruininks-Osertesky Test of Motor Proficiency (BOT) subscales of (1) Visual Motor Control, (2) Upper limb Speed, and (3) Strength, Physical and Neurological Evaluation for Soft Signs (PANESS), and Hand Strength Dynamometer. BOT assess the child's motor development and includes standard scores (mean=100, SD=15) and subtest scores and is normed for sex and age (4-14.5 years). PANESS assesses the time required to press thumb to 4 fingers 20 times for the dominant and nondominant hands and includes standard scores (mean=100, SD=15) with age-specific norms (4-18 years). Hand strength dynamometer assess hand strength in the dominant and nondominant hands and includes standard scores (mean=100, SD=15). Data is expressed as standard scores with mean of 100 and SD of 15. The minimum standard score is 50; the maximum standard score is 145. Higher scorers imply better function. (NCT00348946)
Timeframe: 2 years per subject

,
Interventionscore on a scale (Mean)
BOT Visual-motor control SSBOT Upper limb speed SSBOT Strength SSHand Dynamometer SS- dominant handPANESS SS- dominant hand
Oxandrolone86928812391
Placebo81898511891

Psychosocial and Behavior Domain

Outcome measures were tested using the following social assessments: The Child Behavior Checklist (CBCL) and The Children's Depression Inventory (CDI). The CBCL is standardized measure of behavior problems and social competency normed for children ages 4-16. Higher scores indicate more problems, with the cutoff for the clinical range at a t score greater than or equal to 67. The CDI assess cognitive, affective and behavioral signs of depression in children ages 6-17. The CDI total score reflects the presence of overall depressive symptoms. All scores are expressed as t-scores with a mean of 50 and SD of 10. Lower scores imply better function and higher scores indicate more problem behaviors. (NCT00348946)
Timeframe: 2 years per participants

,
Interventionscore on a scale (Mean)
CBCL: behavior total t-scoreCBCL: internalizing total t-scoreCBCL: externalizing total t-scoreCDI: total t-score
Oxandrolone56545145
Placebo59575447

Working Memory/Attention

Outcome measures were tested using the following cognitive assessments: Digit Span Backward, A Neuropsychological Assessment (NEPSY) subscales of (1) Phonemic Fluency and (2) Semantic Fluency, and Connors' Continuous Performance Test (CPT-II) subscales (1) Omissions, (2) Commissions, (3) Hit Reaction, (4) Variability, and (5) Preservations. Digit Span Backward tests working memory and is normed for children ages 5-16 years. Phonemic Fluency measures the number of words that the child can name beginning with the letters F and S (ages 6-12). Semantic Fluency measures the number of words the child can name in the categories food and drink (ages 4-12). CPT-II measures the ability to maintain attention over an extended period of time. All scores are reported as standard scores with a mean of 100 and SD of 15. The minimum standard score is 50; the maximum standard score is 145. Higher scores imply better function. (NCT00348946)
Timeframe: 2 years per participant

,
Interventionscore on a scale (Mean)
Digit span backwardPhonemic fluencySemantic fluencyCPT: omissionsCPT: commissionsCPT: hit reaction timeCPT variabilityCPT: preservations
Oxandrolone96959988101848676
Placebo92919483100808674

Trials

2 trials available for oxandrolone and Depression

ArticleYear
Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome.
    Hormones and behavior, 2015, Volume: 69

    Topics: Adolescent; Adult; Androgens; Cognition; Depression; Emotional Intelligence; Emotions; Estrogens; Fe

2015
Androgen Treatment Effects on Motor Function, Cognition, and Behavior in Boys with Klinefelter Syndrome.
    The Journal of pediatrics, 2017, Volume: 185

    Topics: Androgens; Anxiety; Child; Child Behavior; Child, Preschool; Cognition; Depression; Double-Blind Met

2017

Other Studies

1 other study available for oxandrolone and Depression

ArticleYear
Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-α.
    Behavioural brain research, 2021, 09-24, Volume: 414

    Topics: Anabolic Agents; Animals; Anti-Inflammatory Agents; Behavior, Animal; Cytokines; Depression; Disease

2021